MetLife Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
25,947
+2,223
| +9% | +$113K | 0.01% | 1175 |
|
|
2025
Q1 | $1.07M | Sell |
23,724
-361
| -1% | -$16.3K | 0.01% | 1335 |
|
|
2024
Q4 | $996K | Buy |
24,085
+1,356
| +6% | +$56.1K | 0.01% | 1415 |
|
|
2024
Q3 | $886K | Hold |
22,729
| – | – | 0.01% | 1459 |
|
|
2024
Q2 | $777K | Buy |
22,729
+8,604
| +61% | +$294K | ﹤0.01% | 1488 |
|
|
2024
Q1 | $355K | Sell |
14,125
-32,628
| -70% | -$820K | ﹤0.01% | 1869 |
|
|
2023
Q4 | $1.38M | Buy |
46,753
+32,628
| +231% | +$963K | 0.01% | 1134 |
|
|
2023
Q3 | $446K | Hold |
14,125
| – | – | ﹤0.01% | 1706 |
|
|
2023
Q2 | $365K | Buy |
14,125
+5,183
| +58% | +$134K | ﹤0.01% | 1897 |
|
|
2023
Q1 | $215K | Buy |
8,942
+514
| +6% | +$12.3K | ﹤0.01% | 2175 |
|
|
2022
Q4 | $164K | Hold |
8,428
| – | – | ﹤0.01% | 2369 |
|
|
2022
Q3 | $177K | Hold |
8,428
| – | – | ﹤0.01% | 2374 |
|
|
2022
Q2 | $164K | Buy |
+8,428
| New | +$164K | ﹤0.01% | 2446 |
|